Quantum BioPharma (NASDAQ: QNTM) advances diversified platform with MS drug Lucid-MS and UNBUZZD for alcohol misuse, targeting neurodegenerative and metabolic disorders
2026/07/10
Lucid (LCID) stock jumped 10% after drawing $800M from Saudi-backed credit facility. CFO transition announced. Q2 earnings expected August 4. The post Lucid (LCID
2026/07/07
TLDR Lucid (LCID) stock rose 10% on Monday to $6.69 Lucid drew $800M from a delayed-draw term loan facility backed by Saudi Arabia’s Public Investment Fund affiliate
Lucid Stock is at a crossroads. LCID surged roughly 20% on a new executive team announcement, then pulled back on a Q2 delivery miss, closing July 6 at $6.66. The
TLDRs; Lucid stock climbed 9.5% after the EV maker accessed an $800 million financing facility backed by Saudi Arabia’s Public Investment Fund. The funding announcement
Tesla stock faces mounting bearish pressure heading into July 2026. TSLA closed at $393.45 on July 2nd after an aggressive reversal from $432.35. The breakdown
2026/07/06
Lucid Group (LCID) stock fell 7.62% following Q2 production data and CFO transition. New leadership appointments aim to streamline operations. The post Lucid Group
2026/07/03
TLDR LCID fell 7.62% to $6.13 after Lucid reported Q2 output figures. Lucid produced 4,774 vehicles and delivered 3,953 vehicles in Q2. Alexander De Bock will join
Tesla (TSLA) stock dropped 6.5% after Q2 2026 deliveries reached 480,126 vehicles, beating forecasts. Europe up 108% YoY, but US demand weakens post-credit. The
2026/07/02
TLDR Tesla delivered 480,126 vehicles in Q2 2026, beating the 397,466 Bloomberg consensus estimate by over 20% Deliveries were up 25% year-over-year and 34% quarter